Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunanda Singh

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Breast Cancer : Basic and Clinical Research|February 14, 2018
Suppression of Breast Cancer Cell Proliferation by Selective Single-Domain Antibody for Intracellular STAT3Sunanda Singh, Genoveva Murillo, Dong Chen, et al.
International Journal of Molecular Sciences|March 11, 2023
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 InhibitionSunanda Singh, Hector J Gomez, Shreya Thakkar, et al.
International Journal of Molecular Sciences|July 27, 2022
A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent CancersSunanda Singh, Genoveva Murillo, Justin Richner, et al.
Cells|June 26, 2024
A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)Evaristus C Mbanefo, Allison Seifert, Manoj Kumar Yadav, et al.
Frontiers in Immunology|October 4, 2021
STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in MiceEvaristus C Mbanefo, Ming Yan, Minkyung Kang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Breast Cancer : Basic and Clinical Research|February 14, 2018
Suppression of Breast Cancer Cell Proliferation by Selective Single-Domain Antibody for Intracellular STAT3Sunanda Singh, Genoveva Murillo, Dong Chen, et al.
International Journal of Molecular Sciences|March 11, 2023
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 InhibitionSunanda Singh, Hector J Gomez, Shreya Thakkar, et al.
International Journal of Molecular Sciences|July 27, 2022
A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent CancersSunanda Singh, Genoveva Murillo, Justin Richner, et al.
Cells|June 26, 2024
A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)Evaristus C Mbanefo, Allison Seifert, Manoj Kumar Yadav, et al.
Frontiers in Immunology|October 4, 2021
STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in MiceEvaristus C Mbanefo, Ming Yan, Minkyung Kang, et al.
Pageof 1